Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nivalis Therapeutics Inc (NASDAQ:NVLS)

During the Trading Day
14.43 +0.01 / +0.07%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
14.47 +0.0423 / +0.29%
 
Volume: 2.2K
No recent news for Nivalis Therapeutics Inc.

Today’s Trading

Previous close14.42
Today’s open14.50
Day’s range14.21 - 14.67
Volume44,742
Average volume (3 months)--
Market cap$222.8M
Dividend yield--
Data as of 3:59pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)+10.08%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
--China Health Group I...-0.03-13.06%
HSKAHeska Corp+0.70+2.07%
DRNADicerna Pharmaceutic...+0.74+6.98%
ECYTEndocyte Inc+0.16+3.11%
Data as of 3:59pm ET, 09/02/2015

Financials

Next reporting dateDecember 2, 2015
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$0.00
Annual profit (last year)-$15.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon Congleton
Chief Operating Officer
Janice Troha
Corporate headquarters
Boulder, Colorado

Forecasts

Partner Offers